Patents by Inventor Jasna Dogan

Jasna Dogan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11667646
    Abstract: Disclosed are solid state forms of Rucaparib and of Rucaparib salts, and pharmaceutical compositions thereof.
    Type: Grant
    Filed: December 15, 2020
    Date of Patent: June 6, 2023
    Assignee: ASSIA CHEMICAL INDUSTRIES LTD.
    Inventors: Dijana S. Samec, Jasna Dogan, Tomislav Biljan, Maja M. Skugor, Moris Mihovilovic, Tina Mundorfer, Nikolina Janton, Mihaela Tuksar, Sara M. Pipercic, Nea Baus Topic
  • Publication number: 20220135548
    Abstract: The present disclosure relates to solid state forms of Encequidar (previously referred to as HM-30181A) base, Encequidar ((HM-30181A) mesylate, co-crystals of Encequidar (HM-30181A) mesylate, processes for preparation thereof, as well as pharmaceutical compositions including the same.
    Type: Application
    Filed: February 14, 2020
    Publication date: May 5, 2022
    Inventors: Petar Bibuliç, Dijana Skalec Samec, Marina Marinkovic, Jasna Dogan
  • Publication number: 20210094962
    Abstract: Disclosed are solid state forms of Rucaparib and of Rucaparib salts, and pharmaceutical compositions thereof.
    Type: Application
    Filed: December 15, 2020
    Publication date: April 1, 2021
    Inventors: Dijana S. Samec, Jasna Dogan, Tomislav Biljan, Maja M. Skugor, Moris Mihovilovic, Tina Mundorfer, Nikolina Janton, Mihaela Tuksar, Sara M. Pipercic, Nea Baus Topic
  • Patent number: 10875870
    Abstract: Disclosed are solid state forms of Rucaparib and of Rucaparib salts, and pharmaceutical compositions thereof.
    Type: Grant
    Filed: January 23, 2018
    Date of Patent: December 29, 2020
    Inventors: Dijana Skalec Samec, Jasna Dogan, Tomislav Biljan, Maja Matanovic Skugor, Moris Mihovilovic, Tina Mundorfer, Nikolina Janton, Mihaela Tuksar, Sara Morasi Pipercic, Nea Baus
  • Patent number: 10807953
    Abstract: The present disclosure relates to novel, safe and efficient processes for the synthesis of Pimavanserin and salts thereof, as well as novel intermediates that can be used in these processes.
    Type: Grant
    Filed: May 28, 2019
    Date of Patent: October 20, 2020
    Assignee: Pliva Hrvatska D.O.O.
    Inventors: Tomislav Biljan, Jasna Dogan, Leonid Metsger, Sara Morasi Pipercic, Marina Ratkaj, Maja Matanovic Skugor, Yi Wang
  • Publication number: 20190389871
    Abstract: Disclosed are solid state forms of Rucaparib and of Rucaparib salts, and pharmaceutical compositions thereof.
    Type: Application
    Filed: January 23, 2018
    Publication date: December 26, 2019
    Inventors: Dijana Skalec Samec, Jasna Dogan, Tomislav Biljan, Maja Matanovic Skugor, Moris Mihovilovic, Tina Mundorfer, Nikolina Janton, Mihaela Tuksar, Sara Morasi Pipercic, Nea Baus
  • Publication number: 20190276401
    Abstract: The present disclosure relates to novel, safe and efficient processes for the synthesis of Pimavanserin and salts thereof, as well as novel intermediates that can be used in these processes.
    Type: Application
    Filed: May 28, 2019
    Publication date: September 12, 2019
    Inventors: Tomislav BILJAN, Jasna DOGAN, Leonid METSGER, Sara Morasi PIPERCIC, Marina RATKAJ, Maja Matanovic SKUGOR, Yi WANG
  • Patent number: 10343993
    Abstract: The present disclosure relates to novel, safe and efficient processes for the synthesis of Pimavanserin and salts thereof, as well as novel intermediates that can be used in these processes.
    Type: Grant
    Filed: March 2, 2016
    Date of Patent: July 9, 2019
    Assignee: Pliva Hrvatska d.o.o.
    Inventors: Tomislav Biljan, Jasna Dogan, Leonid Metsger, Sara Morasi Pipercic, Marina Ratkaj, Maja Matanovic Skugor, Yi Wang
  • Publication number: 20180037549
    Abstract: The present disclosure relates to novel, safe and efficient processes for the synthesis of Pimavanserin and salts thereof, as well as novel intermediates that can be used in these processes.
    Type: Application
    Filed: March 2, 2016
    Publication date: February 8, 2018
    Inventors: Tomislav BILJAN, Jasna DOGAN, Leonid METSGER, Sara Morasi PIPERCIC, Marina RATKAJ, Maja Matanovic SKUGOR, Yi WANG
  • Patent number: 9505744
    Abstract: The present invention provides solid state forms of Vilazodone and Vilazodone hydrochloride, processes for preparing these solid state forms, and pharmaceutical compositions comprising one or more of these solid state forms.
    Type: Grant
    Filed: November 21, 2012
    Date of Patent: November 29, 2016
    Assignee: Assia Chemical Industries LTD.
    Inventors: Edislav Leksic, Dubravka Pavlicic, Dijana Skalec Samec, Jasna Dogan
  • Publication number: 20140323498
    Abstract: The present invention provides solid state forms of Vilazodone and Vilazodone hydrochloride, processes for preparing these solid state forms, and pharmaceutical compositions comprising one or more of these solid state forms
    Type: Application
    Filed: November 21, 2012
    Publication date: October 30, 2014
    Inventors: Edislav Leksic, Dubravka Pavlicic, Dijana Skalec Samec, Jasna Dogan
  • Publication number: 20130035485
    Abstract: In one embodiment the present invention encompasses 4-(2,6-dichloropyrimidin-4-yloxy)-3,5-dimethylbenzonitrile (“ETHER”), 4-(4,6-dichloropyrimidin-2-yloxy)-3,5-dimethyl-benzonitrile (“ETHER C-2 isomer”), mixtures and salts thereof of. The present invention encompasses the use of ETHER and salts thereof to prepare Etravirine and Etravirine intermediates, and salts thereof. In another embodiment the present invention encompasses the use of ETHER and salts thereof to prepare debrometravirine (“DEBETV”) and salts thereof. In yet another embodiment the present invention encompasses the use of ETHER and salts thereof to prepare 4-(6-chloro-2-(4-cyanophenylamino)pyrimidin-4-yloxy)-3,5-dimethyl-benzonitrile (“ARCPBN”) and salts thereof.
    Type: Application
    Filed: March 2, 2012
    Publication date: February 7, 2013
    Inventors: Irena KRIZMANIC, Jasna Dogan, Marina Marinkovic, Maja Sepelj
  • Patent number: 8153790
    Abstract: In one embodiment the present invention encompasses 4-(2,6-dichloropyrimidin-4-yloxy)-3,5-dimethylbenzonitrile (“ETHER”), 4-(4,6-dichloropyrimidin-2-yloxy)-3,5-dimethyl-benzonitrile (“ETHER C-2 isomer”), mixtures and salts thereof of. The present invention encompasses the use of ETHER and salts thereof to prepare Etravirine and Etravirine intermediates, and salts thereof. In another embodiment the present invention encompasses the use of ETHER and salts thereof to prepare debrometravirine (“DEBETV”) and salts thereof. In yet another embodiment the present invention encompasses the use of ETHER and salts thereof to prepare 4-(6-chloro-2-(4-cyanophenylamino)pyrimidin-4-yloxy)-3,5-dimethyl-benzonitrile (“ARCPBN”) and salts thereof. The compound, 4-(2,6-dichloropyrimidin-4-yloxy)-3,5-dimethylbenzonitrile “ETHER” of formula (A) wherein n is either 0 or 1 and HA is an acid.
    Type: Grant
    Filed: July 27, 2010
    Date of Patent: April 10, 2012
    Inventors: Irena Krizmanić, Jasna Dogan, Marina Marinković, Maja {hacek over (S)}epelj
  • Publication number: 20110275812
    Abstract: In one embodiment the present invention encompasses 4-(2,6-dichloropyrimidin-4-yloxy)-3,5-dimethylbenzonitrile (“ETHER”), 4-(4,6-dichloropyrimidin-2-yloxy)-3,5-dimethyl-benzonitrile (“ETHER C-2 isomer”), mixtures and salts thereof of. The present invention encompasses the use of ETHER and salts thereof to prepare Etravirine and Etravirine intermediates, and salts thereof. In another embodiment the present invention encompasses the use of ETHER and salts thereof to prepare debrometravirine (“DEBETV”) and salts thereof. In yet another embodiment the present invention encompasses the use of ETHER and salts thereof to prepare 4-(6-chloro-2-(4-cyanophenylamino)pyrimidin-4-yloxy)-3,5-dimethyl-benzonitrile (“ARCPBN”) and salts thereof. The compound, 4-(2,6-dichloropyrimidin-4-yloxy)-3,5-dimethylbenzonitrile “ETHER” of formula (A) wherein n is either 0 or 1 and HA is an acid.
    Type: Application
    Filed: July 27, 2010
    Publication date: November 10, 2011
    Inventors: Irena Krizmanic, Jasna Dogan, Marina Marinkovic, Maja Sepelj
  • Publication number: 20090298879
    Abstract: The present invention relates to impurities of donepezil, or a pharmaceutically acceptable salt thereof, which may be produced during synthesis and storage of donepezil, or a pharmaceutically-acceptable salt thereof, and to methods of identifying such impurities. The invention also relates to the use of these impurities in analytical techniques and to product that contain certain low levels of these impurities in particular the following impurities are disclosed: formula (I) and formula (II).
    Type: Application
    Filed: May 18, 2007
    Publication date: December 3, 2009
    Applicant: PLIVA Hrvatska d.o.o.
    Inventors: Irena Krizmanic, Lidija Lerman, Zrinka Samardzic, Katarzyna Kaczorowska, Andrzej Manikowski, Barbara Zioro, Ivica Grebenar, Jasna Dogan Koruznjak